Chromanone-A Prerogative Therapeutic Scaffold: An Overview

Overview

Journal Arab J Sci Eng

Publisher Springer

Date 2021 Jul 6

PMID 34226859

Citations 6

Authors

Sonia Kamboj

Randhir Singh

Affiliations

Soon will be listed here.

Abstract

Chromanone or Chroman-4-one is the most important and interesting heterobicyclic compound and acts as a building block in medicinal chemistry for isolation, designing and synthesis of novel lead compounds. Structurally, absence of a double bond in chromanone between C-2 and C-3 shows a minor difference from chromone but exhibits significant variations in biological activities. In the present review, various studies published on synthesis, pharmacological evaluation on chroman-4-one analogues are addressed to signify the importance of chromanone as a versatile scaffold exhibiting a wide range of pharmacological activities. But, due to poor yield in the case of chemical synthesis and expensive isolation procedure from natural compounds, more studies are required to provide the most effective and cost-effective methods to synthesize novel chromanone analogs to give leads to chemistry community. Considering the versatility of chromanone, this review is designed to impart comprehensive, critical and authoritative information about chromanone template in drug designing and development.

Citing Articles

Synthesis, molecular docking studies and biological evaluation of N-(4-oxo-2-(trifluoromethyl)-4H-chromen-7-yl) benzamides as potential antioxidant, and anticancer agents.

Jorepalli S, Adikay S, Chinthaparthi R, Gangireddy C, Koduru J, Karri R Sci Rep. 2024; 14(1):9866.

PMID: 38684797 PMC: 11058781. DOI: 10.1038/s41598-024-59166-5.

Amino-7,8-dihydro-4H-chromenone derivatives as potential inhibitors of acetylcholinesterase and butyrylcholinesterase for Alzheimer's disease management; in vitro and in silico study.

Asadipour A, Pourshojaei Y, Mansouri M, Mahdavizadeh E, Irajie C, Mottaghipisheh J BMC Chem. 2024; 18(1):70.

PMID: 38600537 PMC: 11007943. DOI: 10.1186/s13065-024-01170-x.

Synthesis of cyclobutane-fused chromanones gold-mediated photocatalysis.

Voloshkin V, Villa M, Martynova E, Belis M, Van Hecke K, Ceroni P Chem Sci. 2024; 15(12):4571-4580.

PMID: 38516071 PMC: 10952090. DOI: 10.1039/d3sc06675d.

Novel 4-Chromanone-Derived Compounds as Plant Immunity Inducers against CMV Disease in spp. (Passion Fruit).

Wu T, Yu L, Xiao L, Wang T, Li P, Mu B Molecules. 2024; 29(5).

PMID: 38474557 PMC: 10934444. DOI: 10.3390/molecules29051045.

Asymmetric Radical Bicyclization for Stereoselective Construction of Tricyclic Chromanones and Chromanes with Fused Cyclopropanes.

Lee W, Wang J, Zhu Y, Zhang X J Am Chem Soc. 2023; 145(21):11622-11632.

PMID: 37129381 PMC: 10249947. DOI: 10.1021/jacs.3c01618.

References

Jaracz S, Chen J, Kuznetsova L, Ojima I . Recent advances in tumor-targeting anticancer drug conjugates. Bioorg Med Chem. 2005; 13(17):5043-54. DOI: 10.1016/j.bmc.2005.04.084. View

Vargas E, Echeverri F, Upegui Y, Robledo S, Quinones W . Hydrazone Derivatives Enhance Antileishmanial Activity of Thiochroman-4-ones. Molecules. 2017; 23(1). PMC: 6017792. DOI: 10.3390/molecules23010070. View

Yempala T, Sriram D, Yogeeswari P, Kantevari S . Molecular hybridization of bioactives: synthesis and antitubercular evaluation of novel dibenzofuran embodied homoisoflavonoids via Baylis-Hillman reaction. Bioorg Med Chem Lett. 2012; 22(24):7426-30. DOI: 10.1016/j.bmcl.2012.10.056. View

Javan Maasomi Z, Pilehvar Soltanahmadi Y, Dadashpour M, Alipour S, Abolhasani S, Zarghami N . Synergistic Anticancer Effects of Silibinin and Chrysin in T47D Breast Cancer Cells. Asian Pac J Cancer Prev. 2017; 18(5):1283-1287. PMC: 5555536. DOI: 10.22034/APJCP.2017.18.5.1283. View

Shen Y, Zhang J, Sheng R, Dong X, He Q, Yang B . Synthesis and biological evaluation of novel flavonoid derivatives as dual binding acetylcholinesterase inhibitors. J Enzyme Inhib Med Chem. 2008; 24(2):372-80. DOI: 10.1080/14756360802187885. View

Shi L, Feng X, Cui J, Fang L, Hua Du G, Li Q . Synthesis and biological activity of flavanone derivatives. Bioorg Med Chem Lett. 2010; 20(18):5466-8. DOI: 10.1016/j.bmcl.2010.07.090. View

Murti Y, Mishra P . Synthesis and evaluation of flavanones as anticancer agents. Indian J Pharm Sci. 2014; 76(2):163-6. PMC: 4023286. View

Kupcewicz B, Balcerowska-Czerniak G, Malecka M, Paneth P, Krajewska U, Rozalski M . Structure-cytotoxic activity relationship of 3-arylideneflavanone and chromanone (E,Z isomers) and 3-arylflavones. Bioorg Med Chem Lett. 2013; 23(14):4102-6. DOI: 10.1016/j.bmcl.2013.05.044. View

Calvo M . Homoisoflavanones from Ledebouria floribunda. Fitoterapia. 2008; 80(2):96-101. DOI: 10.1016/j.fitote.2008.10.006. View

10.

Wing K . RH 5849, a nonsteroidal ecdysone agonist: effects on a Drosophila cell line. Science. 1988; 241(4864):467-9. DOI: 10.1126/science.3393913. View

11.

Dupuy J, Ostacher M, Huffman J, Perlis R, Nierenberg A . A critical review of pharmacotherapy for major depressive disorder. Int J Neuropsychopharmacol. 2011; 14(10):1417-31. DOI: 10.1017/S1461145711000083. View

12.

Kopustinskiene D, Jakstas V, Savickas A, Bernatoniene J . Flavonoids as Anticancer Agents. Nutrients. 2020; 12(2). PMC: 7071196. DOI: 10.3390/nu12020457. View

13.

Kebriaeezadeh A, Emami S, Ebrahimi M, Sharifzadeh M, Khorasani R, Shafiee A . Anticonvulsant and antiepileptogenic effects of azolylchromanones on lithium-pilocarpine induced seizures and pentylenetetrazole-kindling model of epilepsy. Biomed Pharmacother. 2008; 62(4):208-11. DOI: 10.1016/j.biopha.2007.12.003. View

14.

Tait S, Salvati A, Desideri N, Fiore L . Antiviral activity of substituted homoisoflavonoids on enteroviruses. Antiviral Res. 2006; 72(3):252-5. DOI: 10.1016/j.antiviral.2006.07.003. View

15.

Di Pisa F, Landi G, Iacono L, Pozzi C, Borsari C, Ferrari S . Chroman-4-One Derivatives Targeting Pteridine Reductase 1 and Showing Anti-Parasitic Activity. Molecules. 2017; 22(3). PMC: 6155272. DOI: 10.3390/molecules22030426. View

16.

Lopez-Lazaro M . Flavonoids as anticancer agents: structure-activity relationship study. Curr Med Chem Anticancer Agents. 2003; 2(6):691-714. DOI: 10.2174/1568011023353714. View

17.

Cywin C, Firestone R, McNeil D, Grygon C, Crane K, White D . The design of potent hydrazones and disulfides as cathepsin S inhibitors. Bioorg Med Chem. 2003; 11(5):733-40. DOI: 10.1016/s0968-0896(02)00468-6. View

18.

Roberson E, Mucke L . 100 years and counting: prospects for defeating Alzheimer's disease. Science. 2006; 314(5800):781-4. PMC: 3544944. DOI: 10.1126/science.1132813. View

19.

Chen X, Mukwaya E, Wong M, Zhang Y . A systematic review on biological activities of prenylated flavonoids. Pharm Biol. 2013; 52(5):655-60. DOI: 10.3109/13880209.2013.853809. View

20.

Mujahid M, Gonnade R, Yogeeswari P, Sriram D, Muthukrishnan M . Synthesis and antitubercular activity of amino alcohol fused spirochromone conjugates. Bioorg Med Chem Lett. 2013; 23(5):1416-9. DOI: 10.1016/j.bmcl.2012.12.073. View